ARIH2OS
Uncharacterized protein ARIH2OS
Also known as: ARI2O_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for ARIH2OS in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
290 residues, UniProt reviewed canonical sequence.
>Q8N7S6|ARIH2OS
1 MLGQRAGDGE RPGLPGDGEG GVPARPGRRA ERPPQRPAKV NKAVTCAAHL PGAAASRPLS
61 PNKPDRVRPG QRDRIGAKRQ RRRRADAGQA RAASSRRVVP TAPEVLGAVA SLPDRGRPTV
121 ARVATGSRLE GLFSAASLKL SALTQSLTRV RQAPTASGAT IRLPASPVEM FLTSAFLTGF
181 SFHCLYSGIG HGEDILASVE QITIVSRPLS GQRGAGPGNS AYTPRRSQGG PRAATTPGFR
241 FPCRGLVRRA VLRLTVTVQD CILTALLAVS FHSIGVVIMT SSYLLGPVVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARIH2OS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.66
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- -0.81
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARIH2OS as an antibody target. Whether an autoantibody or antibody against ARIH2OS could matter depends on whether native ARIH2OS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARIH2OS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARIH2OS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...